depression
CONCLUSION: Depressed HIV-seropositive outpatients respond to       nefazodone comparably to other outpatient populations and have few adverse       effects, suggesting that nefazodone may have a role in the treatment of       depression in HIV-seropositive patients.
CONCLUSION: Depressed HIV-seropositive outpatients respond to       nefazodone comparably to other outpatient populations and have few adverse       effects, suggesting that nefazodone may have a role in the treatment of        @SUBJECT$   @PREDICAT$  HIV-seropositive  @OBJECT$ .